PubRank

Aiden Haghikia

Author PubWeight™ 25.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 2009 1.63
2 Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J 2010 1.14
3 Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J Mol Med (Berl) 2010 1.13
4 Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler 2011 1.05
5 Exercise can rescue recognition memory impairment in a model with reduced adult hippocampal neurogenesis. Front Behav Neurosci 2010 0.98
6 Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model. Glia 2005 0.95
7 Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model. Brain Res 2010 0.94
8 Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther Adv Neurol Disord 2012 0.93
9 Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Mult Scler 2011 0.92
10 Allergic and nonallergic delayed infusion reactions during natalizumab therapy. Arch Neurol 2008 0.90
11 Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Mult Scler 2010 0.89
12 Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int J Neuropsychopharmacol 2007 0.88
13 Parenthood and immunomodulation in patients with multiple sclerosis. J Neurol 2009 0.85
14 PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener 2011 0.84
15 Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis. Arch Neurol 2009 0.83
16 Dexamethasone differentially regulates functional membrane properties in glioma cell lines and primary astrocytes in vitro. J Neurooncol 2010 0.82
17 Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation. Br J Pharmacol 2011 0.82
18 Increased MS relapse rate during assisted reproduction technique. J Neurol 2008 0.81
19 Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability. Neurogenetics 2015 0.81
20 An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis. J Neuroimmunol 2013 0.80
21 Managing MS in a changing treatment landscape. J Neurol 2011 0.79
22 Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy. Mult Scler 2012 0.77
23 Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity 2016 0.76
24 Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous system. J Neuroimmunol 2009 0.75
25 The agony of choice: diagnosis of cervical artery dissection by means of duplexsonography or magnetic resonance imaging? Cerebrovasc Dis 2009 0.75
26 Wheels within wheels: multifocal autoimmune myelitis in a woman with Huntington's disease. J Neurol 2012 0.75
27 Monitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters. Acta Derm Venereol 2012 0.75
28 Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis. Int Immunopharmacol 2012 0.75